Prothena (PRTA)
(Real Time Quote from BATS)
$21.69 USD
-0.31 (-1.41%)
Updated Sep 24, 2024 01:48 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Prothena (PRTA) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$62.50 | $94.00 | $24.00 | 184.09% |
Price Target
Based on short-term price targets offered by eight analysts, the average price target for Prothena comes to $62.50. The forecasts range from a low of $24.00 to a high of $94.00. The average price target represents an increase of 184.09% from the last closing price of $22.00.
Analyst Price Targets (8 )
Broker Rating
Prothena currently has an average brokerage recommendation (ABR) of 1.44 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by nine brokerage firms. The current ABR compares to an ABR of 1.44 a month ago based on nine recommendations.
Of the nine recommendations deriving the current ABR, seven are Strong Buy, representing 77.78% of all recommendations. A month ago, Strong Buy represented 77.78%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 7 | 7 | 7 | 7 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.44 | 1.44 | 1.44 | 1.44 | 1.44 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/14/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/12/2024 | Cantor Fitzgerald & Co | Charles C Duncan | Strong Buy | Strong Buy |
8/8/2024 | Piper Sandler | Yasmeen Rahimi | Strong Buy | Strong Buy |
8/8/2024 | SVB Securities | Rudy Li | Strong Buy | Strong Buy |
6/26/2024 | Not Identified | Not Identified | Hold | Hold |
5/9/2024 | JMP Securities | Jason N Butler | Strong Buy | Strong Buy |
3/13/2024 | H.C. Wainwright & Co. | Andrew S Fein | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.44 |
ABR (Last week) | 1.44 |
# of Recs in ABR | 9 |
Average Target Price | $62.50 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 80 of 253 |
Current Quarter EPS Est: | -1.16 |
PRTA FAQs
Prothena Corporation plc (PRTA) currently has an average brokerage recommendation (ABR) of 1.44 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 9 brokerage firms.
The average price target for Prothena Corporation plc (PRTA) is $62.50. The current on short-term price targets is based on 8 reports.
The forecasts for Prothena Corporation plc (PRTA) range from a low of $24 to a high of $94. The average price target represents a increase of $184.09 from the last closing price of $22.00.
The current UPSIDE for Prothena Corporation plc (PRTA) is 184.09%
Based on short-term price targets offered by eight analysts, the average price target for Prothena comes to $62.50. The forecasts range from a low of $24.00 to a high of $94.00. The average price target represents an increase of 184.09% from the last closing price of $22.00.